Department of Life Sciences and Reproduction, Section of Biological Chemistry, University of Verona, Strada Le Grazie 8 37134 Verona, Italy.
Front Biosci (Landmark Ed). 2012 Jan 1;17(2):621-34. doi: 10.2741/3948.
Primary hyperoxaluria type 1 (PH1) is a rare autosomal recessive disorder of glyoxylate metabolism caused by the deficiency of liver peroxisomal alanine:glyoxylate aminotransferase (AGT), a pyridoxal 5'-phosphate (PLP)-dependent enzyme. The PH1 pathogenesis is mostly due to single point mutations (more than 150 so far identified) on the AGXT gene, and is characterized by a marked heterogeneity in terms of genotype, enzymatic and clinical phenotypes. This article presents an up to date review of selected aspects of the biochemical properties of the two allelic forms of AGT and of some PH1-causing variants. These recent discoveries highlight the effects at the protein level of the pathogenic mutations, and, together with previous cell biology and clinical data, (i) improve the understanding of the molecular basis of PH1 pathogenesis, and (ii) help to delineate perspectives for predicting the response to pyridoxine treatment or for suggesting new strategies for PH1 patients bearing the analyzed mutations.
原发性高草酸尿症 1 型(PH1)是一种罕见的常染色体隐性遗传性甘油酸代谢紊乱,由肝过氧化物酶体丙氨酸:乙醛酸氨基转移酶(AGT)缺乏引起,AGT 是一种依赖吡哆醛 5'-磷酸(PLP)的酶。PH1 的发病机制主要归因于 AGXT 基因上的单点突变(迄今为止已鉴定出超过 150 种),其基因型、酶和临床表型具有明显的异质性。本文对两种等位基因形式的 AGT 的生化特性和一些导致 PH1 的变异体的某些方面进行了最新综述。这些新发现强调了致病性突变在蛋白质水平上的影响,并且结合之前的细胞生物学和临床数据,(i)加深了对 PH1 发病机制的分子基础的理解,(ii)有助于为分析突变的 PH1 患者预测对吡哆醇治疗的反应或提出新策略提供依据。